Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 2,485.70
-32.00 (-1.27%)
Nov 21, 2025, 3:29 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 310.43 billion as of November 21, 2025. Its market cap has decreased by -18.89% in one year.
Market Cap
310.43B
Enterprise Value
303.49B
Revenue
49.73B
Ranking
n/a
PE Ratio
31.90
Stock Price
2,485.70
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 310.43B, an increase of 54,766.72%. That is a compound annual growth rate of 30.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 313.56B | -14.37% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | 141.32B | 66.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.26T |
| Divi's Laboratories | 1.69T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.06T |
| Zydus Lifesciences | 933.79B |
| Mankind Pharma | 925.45B |
| Aurobindo Pharma | 700.39B |
| Fortis Healthcare | 695.32B |